Cargando…
Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a rare disorder associated with high morbidity and mortality despite currently available treatments. We compared the phosphoproteome of lung tissue from subjects with idiopathic PAH (iPAH) obtained at the time of lung transplant with control lung tissue. The...
Autores principales: | Sitapara, Ravikumar, Lam, TuKiet T., Gandjeva, Aneta, Tuder, Rubin M., Zisman, Lawrence S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711668/ https://www.ncbi.nlm.nih.gov/pubmed/34966541 http://dx.doi.org/10.1177/20458940211031109 |
Ejemplares similares
-
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension
por: Galkin, Anna, et al.
Publicado: (2022) -
SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling
por: Sitapara, Ravikumar, et al.
Publicado: (2021) -
Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
por: Pullamsetti, Soni Savai, et al.
Publicado: (2023) -
Sex- and estrous-cycle dependent dorsal hippocampal phosphoproteomic changes induced by low-dose ketamine
por: Saland, Samantha K., et al.
Publicado: (2022) -
Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates
por: Goel, Raghuveera Kumar, et al.
Publicado: (2018)